Overview of Regular Dialysis Treatment in <scp>J</scp>apan (as of 31 <scp>D</scp>ecember 2011)
Shigeru Nakai(Japanese Society for Dialysis Therapy), Yoshiharu Tsubakihara(Renal Association), Satoshi Ogata(Japanese Society for Dialysis Therapy), Hidetomo Nakamoto(Renal Association), Kenji Wakai(Japanese Society for Dialysis Therapy), Seiji Hashimoto(Kinan Hospital), Naohiko Fujii(Renal Association), Masatomo Taniguchi(Japanese Society for Dialysis Therapy), Junichiro James Kazama(Japanese Society for Dialysis Therapy), Ikuto Masakane(Japanese Society for Dialysis Therapy), Toshio Shinoda(Renal Association), Hiroshi Nishi(Renal Association), Takashi Shigematsu(Wakayama Medical University), Takeshi Hasegawa(Renal Association), Noritomo Itami(Renal Association), Kunihiro Yamagata(University of Tsukuba), Tetsuo Shoji(Kyushu University), Kunitoshi Iseki(Renal Association), Norio Hanafusa(Tokyo Women's Medical University Hospital), Yuzo Watanabe(Renal Association), Kazuyuki Suzuki(Renal Association), Kenji Tsuchida(Renal Association), Osamu Morita(Renal Association), Seiji Marubayashi(Renal Association), Takayuki Hamano(Japanese Society for Dialysis Therapy), Naoki Kimata(Japanese Society for Dialysis Therapy), Atsushi Wada(Renal Association)
Cited by 198
Related Papers
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821
Brachial-Ankle Pulse Wave Velocity and the Risk Prediction of Cardiovascular Disease
|Hypertension|2017|538
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
|Science Translational Medicine|2009|434
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
|Therapeutic Apheresis and Dialysis|2015|425